Status:
UNKNOWN
Laparoscopic Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy
Lead Sponsor:
Shuguo Zheng, MD
Conditions:
Liver Tumor
Eligibility:
All Genders
18-70 years
Brief Summary
The purpose of this research is evaluate the results with laparoscopic ALPPS procedure in a single center. The validity, feasibility and limitations were assessed objectively through our clinical pros...
Detailed Description
Background: Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) is a breakthrough in the field of hepatobiliary surgery in recent years，which stimulates the remnant liv...
Eligibility Criteria
Inclusion
- Patients with marginally resectable or primarily non-resectable locally advanced liver tumors
- Insufficient future liver remnant (FLR) either in volume or quality
Exclusion
- Unresectable liver metastases in the future liver remnant or unresectable extrahepatic metastases
- Severe portal hypertension
- High anesthesiological risk
- Unresectable primary tumor
Key Trial Info
Start Date :
July 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2022
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT02203409
Start Date
July 1 2014
End Date
August 1 2022
Last Update
January 14 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Southwest Hospital
Chongqing, China, 400038